145 related articles for article (PubMed ID: 12888898)
1. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.
Weichert W; Gekeler V; Denkert C; Dietel M; Hauptmann S
Int J Oncol; 2003 Sep; 23(3):633-9. PubMed ID: 12888898
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma.
Zhang L; Huang J; Yang N; Liang S; Barchetti A; Giannakakis A; Cadungog MG; O'Brien-Jenkins A; Massobrio M; Roby KF; Katsaros D; Gimotty P; Butzow R; Weber BL; Coukos G
Cancer Res; 2006 May; 66(9):4627-35. PubMed ID: 16651413
[TBL] [Abstract][Full Text] [Related]
3. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
Denkert C; Schmitt WD; Berger S; Reles A; Pest S; Siegert A; Lichtenegger W; Dietel M; Hauptmann S
Int J Cancer; 2002 Dec; 102(5):507-13. PubMed ID: 12432554
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis.
Wu TT; Hsieh YH; Wu CC; Hsieh YS; Huang CY; Liu JY
Clin Chim Acta; 2007 Jul; 382(1-2):54-8. PubMed ID: 17459358
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.
Denkert C; Köbel M; Pest S; Koch I; Berger S; Schwabe M; Siegert A; Reles A; Klosterhalfen B; Hauptmann S
Am J Pathol; 2002 Mar; 160(3):893-903. PubMed ID: 11891188
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer.
Fournier DB; Chisamore M; Lurain JR; Rademaker AW; Jordan VC; Tonetti DA
Gynecol Oncol; 2001 Jun; 81(3):366-72. PubMed ID: 11371124
[TBL] [Abstract][Full Text] [Related]
7. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
8. Role of protein kinase C alpha in primary human osteoblast proliferation.
Lampasso JD; Marzec N; Margarone J; Dziak R
J Bone Miner Res; 2002 Nov; 17(11):1968-76. PubMed ID: 12412804
[TBL] [Abstract][Full Text] [Related]
9. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
[TBL] [Abstract][Full Text] [Related]
10. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer.
Regala RP; Weems C; Jamieson L; Khoor A; Edell ES; Lohse CM; Fields AP
Cancer Res; 2005 Oct; 65(19):8905-11. PubMed ID: 16204062
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
12. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
Brustmann H
Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
[TBL] [Abstract][Full Text] [Related]
13. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
[TBL] [Abstract][Full Text] [Related]
15. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Abeler VM; Kopolovic J; Onsrud M; Lazarovici P; Davidson B
Hum Pathol; 2007 Jan; 38(1):140-6. PubMed ID: 16996570
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
17. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma.
Köbel M; Gradhand E; Zeng K; Schmitt WD; Kriese K; Lantzsch T; Wolters M; Dittmer J; Strauss HG; Thomssen C; Hauptmann S
Int J Gynecol Pathol; 2006 Apr; 25(2):121-30. PubMed ID: 16633060
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
[TBL] [Abstract][Full Text] [Related]
19. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.
Kristiansen G; Denkert C; Schlüns K; Dahl E; Pilarsky C; Hauptmann S
Am J Pathol; 2002 Oct; 161(4):1215-21. PubMed ID: 12368195
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]